The recent window is materially active
784 eligible papers appear in the current 30-day evidence window, compared with 157 in the prior 30 days. The busiest visible day is 2026-04-15 with 46 eligible papers.
5.0x prior-window volumeWeekly trend brief
Dementia research is emphasizing screening validity, digital assessment, and progression modeling. The current 30-day evidence window contains 784 eligible papers, 5.0x the prior 30-day window, with 781 abstract-backed papers available for a closer scan. Representative papers point to Alzheimer disease progression modeling, subjective cognitive decline, digital spatial working-memory testing, screening fairness, community prevalence, daily-life cognitive changes, and multimodal clinical/imaging prediction.
784 eligible papers appear in the current 30-day evidence window, compared with 157 in the prior 30 days. The busiest visible day is 2026-04-15 with 46 eligible papers.
5.0x prior-window volume781 recent papers include abstracts, about 100% of the eligible set. That gives the brief enough signal for topic-specific commentary while keeping claims limited to paper metadata and representative titles.
781 abstract-backed papersThe selected papers point toward Alzheimer disease progression modeling, subjective cognitive decline, digital spatial working-memory testing, screening fairness, community prevalence, daily-life cognitive changes, and multimodal clinical/imaging prediction. That gives the brief a visible research direction rather than only a ranked list of recent papers.
8 representative papers8 representative papers span 6 sources, including 1 preprint that should be treated as preliminary.
6 representative sourcesOperator-learning and multimodal clinical/imaging papers keep disease-stage prediction and biomarker dynamics visible.
8 representative papersDigital cognitive tests, measurement bias, calibration, and fairness papers point to practical diagnostic reliability questions.
8 representative papersCommunity prevalence, subjective cognitive decline, and daily-life experience studies broaden the page beyond imaging or model performance.
8 representative papersSelected because it anchors a progression-modeling, assessment-validity, screening-fairness, or lived-experience thread; this paper appears in npj Systems Biology and Applications (2026) and is matched to Dementia and Cognitive Impairment Research. Treat as preliminary because it is marked as a preprint.
Selected because it anchors a progression-modeling, assessment-validity, screening-fairness, or lived-experience thread; this paper appears in Journal of Alzheimer s Disease (2026) and is matched to Dementia and Cognitive Impairment Research.
Selected because it anchors a progression-modeling, assessment-validity, screening-fairness, or lived-experience thread; this paper appears in Journal of Alzheimer s Disease (2026) and is matched to Dementia and Cognitive Impairment Research.
Selected because it anchors a progression-modeling, assessment-validity, screening-fairness, or lived-experience thread; this paper appears in Discover Mental Health (2026) and is matched to Dementia and Cognitive Impairment Research.
Selected because it anchors a progression-modeling, assessment-validity, screening-fairness, or lived-experience thread; this paper appears in Frontiers in Medicine (2026) and is matched to Dementia and Cognitive Impairment Research.
Selected because it anchors a progression-modeling, assessment-validity, screening-fairness, or lived-experience thread; this paper appears in Frontiers in Aging Neuroscience (2026) and is matched to Dementia and Cognitive Impairment Research.
Selected because it anchors a progression-modeling, assessment-validity, screening-fairness, or lived-experience thread; this paper appears in Journal of Alzheimer s Disease (2026) and is matched to Dementia and Cognitive Impairment Research.
Selected because it anchors a progression-modeling, assessment-validity, screening-fairness, or lived-experience thread; this paper appears in bioRxiv (Cold Spring Harbor Laboratory) (2026) and is matched to Dementia and Cognitive Impairment Research.